Please use this identifier to cite or link to this item:
https://dspace.iiti.ac.in/handle/123456789/12011
Title: | Dorzolamide suppresses PKCδ-TIRAP-p38 MAPK signaling axis to dampen the inflammatory response |
Authors: | Rajpoot, Sajjan Jha, Hem Chandra Baig, Mirza Saqib |
Keywords: | AP1;dorzolamide (DZD);macrophages;NF-κB;p38 MAPK;PKCδ;pro-inflammatory cytokines;sepsis;TIRAP |
Issue Date: | 2023 |
Publisher: | Newlands Press Ltd |
Citation: | Rajpoot, S., Kumar, A., Gaponenko, V., Thurston, T. L. M., Mehta, D., Faisal, S. M., . . . Baig, M. S. (2023). Dorzolamide suppresses PKCδ-TIRAP-p38 MAPK signaling axis to dampen the inflammatory response. Future Medicinal Chemistry, 15(6), 533-554. doi:10.4155/fmc-2022-0260 |
Abstract: | Background: Sepsis is a syndrome due to microbial infection causing impaired multiorgan function. Its underlying cause is immune dysfunction and macrophages play an essential role. Methods: TIRAP interaction with PKCδin macrophage was studied, revealing downstream signaling by Western blot and quantitative reverse transcriptase PCR. Dorzolamide (DZD) disrupting TIRAP-PKCδinteraction was identified by virtual screening and validated in vitro and in septic mice. Results: The study highlights the indispensable role of TIRAP-PKCδin p38 MAPK-activation, NF-κB- and AP-1-mediated proinflammatory cytokines expression, whereas DZD significantly attenuated the signaling. Conclusion: Targeting TIRAP-PKCδinteraction by DZD is a novel therapeutic approach for treating sepsis. © 2023 MS Baig. |
URI: | https://doi.org/10.4155/fmc-2022-0260 https://dspace.iiti.ac.in/handle/123456789/12011 |
ISSN: | 1756-8919 |
Type of Material: | Journal Article |
Appears in Collections: | Department of Biosciences and Biomedical Engineering |
Files in This Item:
There are no files associated with this item.
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.
Altmetric Badge: